Skip Navigation
Search

MaryannE rizk, phd

Chief Strategy Officer
Medable

Dr. Rizk is leading the transformation charge in expanding global partner and innovation ecosystems for the modernization of digital trials at Medable, the leader in Decentralized Trials. With more than 20 years of experience, Dr Rizk has been managing partnerships to accelerate clinical development across her career in technology (Oracle, Medidata), pharmaceutical (Merck), and clinical research organizations (IQVIA) and retail pharmacy (CVS).

Her expertise includes providing biopharma executives access to leading innovations that provide scientific insights, intelligence and convenience for patients. Results include acceleration and automation of drug development powered by cloud SaaS platforms, AIML, advanced analytics, connected devices through a leading ecosystem of collaborations and partnerships. 

Before assuming her current role at Medable, Dr.Rizk was awarded with the PharmaVOICE 100 most inspiring leaders in August 2021 as a leading change agent. She earned her PhD, Masters and Bachelor of Engineering at Stevens Institute of Technology where she also is an adjunct professor. Dr Rizk also serves on a number of advisory boards including the Galien Foundation Digital Advisor, HBA and SCRS. She is based in NJ where she enjoys cycling and boating with her kids.